epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Azurette
    desogestrel/ ethinyl estradiol
  • remove Retacrit
    epoetin alfa
  • remove Ruxience (rituximab-pvvr)
    rituximab

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Azurette (desogestrel/ ethinyl estradiol) + Retacrit (epoetin alfa)

Monitor/Modify Tx


desogestrel (contraceptive) + epoetin alfa

monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

ethinyl estradiol (contraceptive) + epoetin alfa

monitor BP, thrombosis s/sx: combo may incr. risk of HTN, thromboembolism (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information